Form 4: CarMax Executive Diane L. Cafritz Reports Stock Option Grant
SEC Form 4
Diane L. Cafritz, EVP, General Counsel & CCO of CarMax Inc., reports the acquisition of 27,416 stock options on May 1, 2024, exercisable in installments starting May 1, 2025.
Summary
- On May 1, 2024, Diane L. Cafritz, EVP, General Counsel & CCO of CarMax Inc., reported acquiring 27,416 stock options.
- These options, granted at a price of $67.21, become exercisable in four equal installments starting May 1, 2025, and expiring on May 1, 2031.
- The stock options are granted in tandem with stock appreciation rights (SARS), where exercising one results in surrendering the other.
- The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated.
- Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing regarding executive compensation. It is neutral in tone and reflects standard corporate practices.
Positives
- The grant of stock options to a key executive aligns their interests with the long-term performance of the company.
- The vesting schedule encourages continued service and commitment from the executive.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the stock options suggests an expectation of continued employment and contribution from the executive.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies like CarMax. They are used to incentivize executives to increase shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the retail and automotive industries.
- Companies like AutoNation and Penske Automotive Group also utilize stock options as part of their executive compensation strategy.
- The vesting schedule and exercise price are typical for such grants, aligning with industry norms for incentivizing long-term performance.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
- The grant could have a minor dilutive effect on existing shareholders if the options are exercised.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of stock option grant and transaction date. |
| 05/01/2025 | First vesting date for one-fourth of the stock options. |
| 05/01/2026 | Second vesting date for one-fourth of the stock options. |
| 05/01/2027 | Third vesting date for one-fourth of the stock options. |
| 05/01/2028 | Fourth vesting date for one-fourth of the stock options. |
| 05/01/2031 | Expiration date of the stock options. |
| 05/03/2024 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.